WO1992021280A1 - Patient headpiece for optical cerebral oximeter - Google Patents
Patient headpiece for optical cerebral oximeter Download PDFInfo
- Publication number
- WO1992021280A1 WO1992021280A1 PCT/US1992/004743 US9204743W WO9221280A1 WO 1992021280 A1 WO1992021280 A1 WO 1992021280A1 US 9204743 W US9204743 W US 9204743W WO 9221280 A1 WO9221280 A1 WO 9221280A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- light
- detectors
- receiver unit
- patient
- recited
- Prior art date
Links
- 230000003287 optical effect Effects 0.000 title claims abstract description 56
- 230000002490 cerebral effect Effects 0.000 title abstract description 7
- 239000004020 conductor Substances 0.000 claims abstract description 34
- 239000000463 material Substances 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims description 14
- 238000001727 in vivo Methods 0.000 claims description 10
- 239000006260 foam Substances 0.000 claims description 8
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 3
- 230000035945 sensitivity Effects 0.000 claims description 2
- 239000012858 resilient material Substances 0.000 claims 13
- 239000011888 foil Substances 0.000 claims 2
- 239000006263 elastomeric foam Substances 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 239000006261 foam material Substances 0.000 abstract description 2
- 210000001061 forehead Anatomy 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 230000005670 electromagnetic radiation Effects 0.000 abstract 1
- 238000004611 spectroscopical analysis Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 230000004044 response Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 210000003625 skull Anatomy 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 210000004720 cerebrum Anatomy 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 241001269524 Dura Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- -1 e.g. Substances 0.000 description 1
- 239000012777 electrically insulating material Substances 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000005686 electrostatic field Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6814—Head
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0091—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for mammography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
- A61B5/02427—Details of sensor
- A61B5/02433—Details of sensor for infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14552—Details of sensors specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14553—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems
- A61B5/4306—Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
- A61B5/4312—Breast evaluation or disorder diagnosis
Definitions
- This invention relates to optical spectrophotometric methods and apparatus, particularly as adapted for use in clinical in vivo procedures involving human patients; more particularly, the invention relates to a patient monitoring device and optical component carrier, preferably in the form of a headpiece, for use on the patient as the patient- spectrophotometer interface, by which optical-response spectrophotometric patient examination data is obtained.
- PCT/US92/ corresponding to United States application Serial No. 07/711,147, filed June 6, 1991, entitled: "Optical Cerebral Oximeter”, in which apparatus and methodology is disclosed for implementing an optical spectrophotometric device for use in monitoring oxidative metabolism in the human brain and providing a readout directly in terms of percent hemoglobin oxygen saturation.
- the present invention is directed to a preferred form of patient headpiece for use in such device, as well as for potential use in other analogous such devices, providing a further advanced and improved "optical probe” or patient-machine interface, by which optical-response data is obtained from the patient and supplied to a spectrophotometric device.
- the present invention provides improvements in optical spectrophotometric sensor assemblies, i.e., "optical probes", particularly adapted for in vivo use as the patient interface in clinical spectrophotometric patient-monitoring apparatus such as the aforementioned cerebral oxi eter.
- the major objectives of the invention, and the advantages attributable thereto, comprise the provision of a new and improved form of patient headpiece for obtaining optical spectrophotometric data on an in vivo basis in clinical use
- the improved apparatus in accordance with the invention includes both general and particular features and attributes of such a device, com ⁇ prising generally a flexible support or component-carrier adapted for comfortably conforming to the shape of the patient's cerebrum or other such anatomical area, with particular component-mounting structure and apparatus for optimizing the introduction of the selected light spectra into a selected internal tissue volume or region of examina ⁇ tion, as well as for enhancing the faithful and accurate detection of the low-level resulting light and corresponding signals produced and processed to obtain the desired biomedical information.
- the invention provides an improved form of such headpiece, together with particular preferred componentry, including optical (light-emitting and detecting) components as well as particular preferred mounting structure and arrangements therefor within the soft, comparatively flexible support or carrier.
- particular preferred componentry including optical (light-emitting and detecting) components as well as particular preferred mounting structure and arrangements therefor within the soft, comparatively flexible support or carrier.
- electrical circuitry is provided for the device and its light-emitting and light-detecting components, together with novel shielding therefor to protect against contamination of the electrical signals representative of the optical data by ambient electromagnetic or electrostatic fields, etc.
- the invention provides novel structural and mounting (securement) means for the electro-optical components as noted above, and further includes means for shielding the same from optical disruption or contamination during use in the anticipated environment, to thereby further enhance the fidelity of the optical response obtained, and the entire apparatus as disclosed is conducive to manufacture as a disposable, single-use component which lends itself readily to customary and familiar clinical sterilization techniques, and is also adapted for rapid connection and disconnection to the spectrophotometric control and processing unit.
- FIG. 1 is a schematic pictorial representation showing a typical operative environment for the apparatus in accordance with the invention, including representative elements thereof;
- Fig. 2 is a side elevation of a preferred embodiment of the invention
- Fig. 3 is an enlarged cross-sectional end elevation taken along the plane III-III of Fig. 2;
- Fig. 4 is an enlarged cross-sectional end elevation taken along the plane IV-IV of Fig. 2;
- Fig. 5 is an enlarged side elevational view of a preferred form of shielding element for use in the apparatus
- Fig. 6 is an enlarged side elevational view of the circuit board which carries the electro-optical components
- Fig. 7 is a fragmentary further enlarged view showing portions of the apparatus shown in Fig. 6;
- Fig. 8 is a fragmentary side elevational view showing a portion of the structure of Fig. 6 with certain of the shielding members in place and others partially removed;
- Fig. 9 is a cross-sectional end elevation taken along the plane IX-IX of Fig. 8;
- Fig. 1 comprises a representative and pictorial showing of a typical clinical setting in which optical spectrophotometric apparatus in accordance with the inven ⁇ tion is to be used, as part of an operative system for monitoring or examining patients.
- Fig. 1 is taken directly from the aforementioned copending application which describes the overall cerebral oximeter system in consider ⁇ able detail. For purposes of the present disclosure, it need only be said that Fig.
- FIG. 1 shows a human patient 10 who is being monitored by an infrared spectroscopy unit 18 via a sensor unit 12 in accordance with the present invention, which is applied to the forehead of the patient 10 to optically access an internal tissue volume or regional field 14 within the cerebrum, directly adjacent the point where sensor 12 is located, but inside of the scalp, skull, and adjacent dura, i.e., within the brain tissue itself.
- the sensor unit 12 is coupled to the spectroscopy unit 18 through a conductor bundle 16 described more particularly hereinafter (shown in a bifurcated, divided form for purposes of illustration, although not actually implemented in this particular physical form in the preferred embodiment) .
- the spectroscopy unit 18 includes a digital computer 20 having a monitor 22 on which visual displays may be perceived.
- the receiver (detector) conductor bundle portion 16a includes an amplification unit 24 disposed a short distance away from the patient 10, as described in more detail hereinafter.
- the preferred embodiment of sensor 12 as described herein preferably comprises an elongated, somewhat rectangu ⁇ lar member (Fig. 2) with rounded corners, from which the conductor bundle 16 extends outwardly.
- sensor assembly 12 preferably comprises a laminar "sandwich" which includes an outer layer (i.e., a cover) having a softly resilient sheet of foam material 26 on the side facing the patient, and an outer backing layer 28 which may be of thinner material which is flexible but not necessarily resilient in character.
- the two layers 26, 28 are secured together adhesively, and between them is disposed an electrical component board 30 described in more detail hereinafter but adhesively secured in place as a unit so that electro-optical components carried thereon such as photodetectors 32, 34 and a light source 36 are disposed in registration with appropriate apertures 132, 134 and 136 formed in the foam layer 26 (Figs. 3 and 4) , through which such optical components may access the patient 10 (by emitting light which transmisses through the scalp, skull and brain tissue of region 14, and then detecting resultant light after it leaves such region and passes back out of the patient through the skull and scalp, etc.).
- electro-optical components carried thereon such as photodetectors 32, 34 and a light source 36 are disposed in registration with appropriate apertures 132, 134 and 136 formed in the foam layer 26 (Figs. 3 and 4) , through which such optical components may access the patient 10 (by emitting light which transmisses through the scalp, skull and brain tissue of region 14, and then detecting resultant light after it leaves such region and
- the electrical component board 30 is preferably much smaller in overall size than the outer dimensions of the foam layer and backing layer 26, 28 which provide the outwardly visible shape of sensor assembly 12 (as shown in Fig. 2) , and preferably comprises a printed circuit board such as that illustrated in Fig. 6; more particularly, such "printed circuit” board 30 preferably comprises a flex circuit 40, having printed conductive strips 38 secured to one side of a stiffly flexible support strata 40' (Fig. 6). Support strata 40' integrally mounts the aforementioned photodetectors 32 and 34, as well as the light source 36, which are adhesively secured to the support strata and electrically connected to the respective strips 38 by a small wire-like conductor 39.
- source 36 comprises a closely-grouped series of light-emitting diodes (L.E.D. 's) which are individually excited through particular ones of the strips 38, i.e., strips 38a, 38b and 38c (Fig. 7), in conjunction with a common ground conductor 38d.
- the conductive strips of flex circuit 40 are electrically connected to the adjacent portion 16a of conductor bundle 16 by soldering the end extremities of the electrical conductors (i.e. wires) 216 inside the conductor bundle 16a to the row of contacts 44 forming the end extremities of conductive strips 38, near one end of the board 30 (Figs. 6 and 8) .
- L.E.D. 's designated 36a, 36b, 36c, each for producing a specifically selected different light wavelength (as referred to in more detail in the above-identified copending application .
- the preferred configuration illus ⁇ trated provides certain advantages, particularly in conjunction with present-day L.E.D.s, which can provide surprising amounts of light intensity from a very small component with relatively low excitation.
- the L.E.D.s 36 produce output intensities of about three milliwatts at ninety degree solid angle and require only about five volts d.c. excitation.
- the photodetectors 32, 34 preferably have sensitivities of about 500 milliamps/watt with peak spectral response at about 900-1000 nm, and are of the low noise type.
- the relative separation of (distance between) the light source 36 and the location of the detec ⁇ tors 32, 34 is of considerable importance to the particular purpose, function and application of the optical spectrophotometric device with which the sensor assembly 12 is to be used, since these distances effectively determine the location and size of the particular internal region 14 which is to be selectably examined by the interrogating light wavelengths.
- the electrical component board 30 is preferably covered on both major sides with a thin, stiffly flexible conductive metal layer such as that shown at 42 in Fig. 5, which adds a degree of structural support (i.e., strengthening of the flex circuit) but more importantly provides shielding against otherwise-disruptive or distorting influences such as electromagnetic or electro ⁇ static fields as well as anomalous ambient light, etc. More particularly, layer 42 shown in Fig.
- layer 42 comprises in effect a mask which fits over the component side of board 30, and is preferably adhesively secured thereto (being electrically insulated from the conductors 38, etc. by the laminate structure of the flex circuit forming board 30, which includes a thin electrically insulating overlay) .
- the opposite side of the flex circuit is also preferably covered by a shield layer 42' essentially similar to layer 42, although of course without the apertures since there are no electro-optical components on the reverse side of board 30. That is, the shielding and supportive layer 42' on the non-component side of flex circuit 40 is simply an imperforate sheet of the same conductive material as layer 42, adhesively secured in place.
- the laminar "sandwich” described above which forms electrical component board 30 is preferably additionally shielded by use of an overlay of conductive sheet material such as a foil-like metal, e.g., copper tape, as designated by the numeral 46 (Fig. 8) , which is wrapped completely around the laminated "sandwich” on all sides except for closely-fitting apertures disposed in registration with apertures 232, 234 and 236 of mask layer 42 (Fig. 5) .
- each of the electro-optical components i.e., source 36 and detectors 32,34
- a shield element 48 Figs.
- foil-like (tape) shielding layer 46 is preferably secured in place by an electrically-conductive adhesive carried on one side, which integrates the tape into the composite shielding provided.
- conductor bundle 16a is preferably in the form of shielded "co-ax" cable, i.e., having a metallic mesh sleeve 16b (Fig. 2) which peri ⁇ pherally surrounds the electrical conductors 216 (which are mutually insulated from one another) , and the sheath 16b (or an integral portion thereof) is extended toward and into contact with the outer shielding layer 42 (Fig. 8) of electrical component board 30, where it is soldered or otherwise secured in place.
- Sheath 16b is preferably disposed inside a generally tubular, rubber-like outer sleeve 116, which is preferably of an electrically insulating material and also serves esthetic purposes.
- the electro-optical components in particular detectors 32 and 34, are extensively shielded by the aforementioned layers 42, 42', 46, mesh patches 48, sheath 16b, etc., since the outer shielding tape layer 46 is also in electrical contact with sheath portion 16b, (through layer 42) and the sheath 16b extends outwardly to the amplifier unit 24, and into contact with a further ground conductor (not specifically shown) contained within conductor bundle 16c, that extends into the spectroscopy unit 18, and is connected to the system ground therewithin.
- This provides substantial protection against distortion for the comparatively low-level electrical signals produced by detectors 32 and 34 in response to receipt of the selected wavelengths of light from source 36 which have transmissed the region 14 being interrogated.
- the amplifier unit 24 at a selected distance away from the sensor 12 (e.g., at least about three feet, and preferably about five to six feet) is also a desirable aspect, since this helps to eliminate the presence of higher voltage or current levels at the sensor itself, close to the patient, while at the same time providing for minimal losses of signal between the patient and the spectroscopy unit 18.
- the particular attributes of the amplifier 24 should be selectively chosen to complement the electro-optical components as well as to provide the desired input levels for the spectroscopy unit.
- the amplifier 24 should be a low-noise device with high input impedance, such as the commercial amplifier unit known as the AD515 (Analog Devices) .
- the photodetectors 32, 34 are current-output devices, and as a result the resistivity of the conductors in cable portion 16a is of less significance.
- the output of amplifier 24, coupled to the spectroscopy unit 18, will be voltage-variant, however.
- the foam layer 26 be of black, light-absorbing material, in order to more effectively isolate ambient light from the electro-optical components 30, 32, 34, as well as to help prevent any possibility of surface leakage between source 36 and detectors 32, 34. This helps ensure that photons received by the detectors have actually transmissed the tissue of the patient, and thus carry desired information.
- the surrounding apertures 132, 134 and 136 for the associated electro-optical components are preferably very closely-fitting (i.e., complementary) to the compo ⁇ nents, to further enhance such shielding effects.
- the rear layer 28, of the sensor assembly is preferably opaque to ambient light, i.e., is of dense and highly-reflective material (preferably being white in color) such as an imperforate sheet of polymeric material.
- the foam layer 26 is preferably of sufficiently open-celled character as to transmit water vapor from the patient, to prevent moisture build up between the outer face of foam layer 26 and the patient.
- One acceptable type of such material is polyurethane foam.
- an optically clear material such as epoxy over the light source 36, i.e., the grouped array of L.E.D.s 36a, 36b, etc.
- the optically clear deposits 50 in effect provide low-loss light guides which actually make contact with the patient (particularly in view of the compressibility of the foam layer 26) to enhance the coupling of light into and out of the patient's tissue.
- the deposit over the source 36 somewhat modifies the resulting form of light emission from the L.E.D.s so that they less resemble a point source than would otherwise be true. That is, the desired form of light from source 36 is diffuse in nature, and of course is further diffused by the highly scattering effect of the brain or other tissue to be transmissed.
Abstract
A thin, lightweight optical source/receiver unit (12) adapted for application to the human forehead, for use in a cerebral oximeter, has a source of electromagnetic radiation of selected wavelengths (36) (e.g., light in the near infrared range) at a first position and a pair of sensors located at particular and differing distances from the source. The source may comprise light-emitting diodes (36a-36b) and the detectors may comprise photosensors (32, 34), all of which are preferably mounted on a small and flexible printed circuit strip (30). Electromagnetic shielding (42) substantially surrounds the source and detectors as well as the adjacent electrical conductors associated with each. The shielded printed circuit (30) and components are housed within layers of thin flexible material, of which the layer that contacts the patient preferably comprises soft, light-absorbing open-celled foam material (26) which is transmissible by water vapor, to dissipate moisture at the patient-sensor interface.
Description
PATIENT HEADPIECE FOR OPTICAL CEREBRAL OXIMETER
TECHNICAL FIELD
This invention relates to optical spectrophotometric methods and apparatus, particularly as adapted for use in clinical in vivo procedures involving human patients; more particularly, the invention relates to a patient monitoring device and optical component carrier, preferably in the form of a headpiece, for use on the patient as the patient- spectrophotometer interface, by which optical-response spectrophotometric patient examination data is obtained.
BACKGROUND
In related prior patents, e.g., U.S. Patent No. 4,570,638, optical spectrophotometric procedures and apparatus are disclosed and described for in vivo clinical application to human patients, as well as a potential broader range of subjects, by which important biomedical information may be obtained which is directly indicative of intrinsic, internal biological and physiological processes, conditions, tissue or substance composition or state, etc., and these prior patents generally contemplate use of certain "optical probes", i.e., optical component mounting and carrying apparatus, by which the selected light wavelengths are emitted and administered to the patient and resulting light is detected and monitored at various positions and points on the patient.
While a principle focus of these prior patents is the use of such spectrophotometric techniques on human anatomy in a manner by which the relative spacing of the light-emitting and light-detecting elements was variable, the underlying significance of such spacing was the important consideration in this regard, and thus the disclo¬ sures in these patents also contemplate comparable or analogous sender-receiver configurations of fixed geometry.
The applicability and value of using such optical spectrophotometric procedures on an in vivo basis with human patients continues to gain credence and recognition, as well as wider understanding, with increasing development and progress. One development evidencing such further progress
is disclosed in my copending application Serial No.
PCT/US92/ , corresponding to United States application Serial No. 07/711,147, filed June 6, 1991, entitled: "Optical Cerebral Oximeter", in which apparatus and methodology is disclosed for implementing an optical spectrophotometric device for use in monitoring oxidative metabolism in the human brain and providing a readout directly in terms of percent hemoglobin oxygen saturation. The present invention is directed to a preferred form of patient headpiece for use in such device, as well as for potential use in other analogous such devices, providing a further advanced and improved "optical probe" or patient-machine interface, by which optical-response data is obtained from the patient and supplied to a spectrophotometric device.
Prior participants in the art have addressed similar underlying considerations, and reference is particularly made to the work of Frans F. Jobsis et al, as represented in and by prior U.S. Patents Nos. 4,223,680; 4,281,645; 4,321,930; 4,380,240; 4,510,938; and 4,805,623. While certain of the underlying concepts and/or scientific assumptions or theories set forth in these patents differ from those addressed by the present inventor, as reflected by the related application and referenced prior patents identified above, these prior patents attributed to Jobsis et al contain considerable information, etc. of interest to the general subject matter hereof, and certain such patents (in particular, Nos. 4,321,930, 4,380,240 and 4,510,938) expressly disclose patient headpieces for use in generally similar in vivo optical spectrophotometric procedures. Accordingly, these and other such prior teachings provide background information of definite interest, and to some extent this may be said in connection with various embodi¬ ments of arterial pulse oximeters patented previously and in common use; for example, see U.S. Patent No. 4,013,067, which shows a flexible strap-like device for carrying optical senders and receivers, adapted for encircling the
finger of the patient and thus accessing arterial blood vessels therewithin.
BRIEF SUMMARY OF INVENTION
As indicated above, the present invention provides improvements in optical spectrophotometric sensor assemblies, i.e., "optical probes", particularly adapted for in vivo use as the patient interface in clinical spectrophotometric patient-monitoring apparatus such as the aforementioned cerebral oxi eter.
Accordingly, the major objectives of the invention, and the advantages attributable thereto, comprise the provision of a new and improved form of patient headpiece for obtaining optical spectrophotometric data on an in vivo basis in clinical use, and the improved apparatus in accordance with the invention includes both general and particular features and attributes of such a device, com¬ prising generally a flexible support or component-carrier adapted for comfortably conforming to the shape of the patient's cerebrum or other such anatomical area, with particular component-mounting structure and apparatus for optimizing the introduction of the selected light spectra into a selected internal tissue volume or region of examina¬ tion, as well as for enhancing the faithful and accurate detection of the low-level resulting light and corresponding signals produced and processed to obtain the desired biomedical information.
In a more particular sense, the invention provides an improved form of such headpiece, together with particular preferred componentry, including optical (light-emitting and detecting) components as well as particular preferred mounting structure and arrangements therefor within the soft, comparatively flexible support or carrier. In addition, a preferred form of electrical circuitry is provided for the device and its light-emitting and light-detecting components, together with novel shielding therefor to protect against contamination of the electrical signals representative of the optical data by ambient electromagnetic or electrostatic fields, etc.
In addition, the invention provides novel structural and mounting (securement) means for the electro-optical components as noted above, and further includes means for shielding the same from optical disruption or contamination during use in the anticipated environment, to thereby further enhance the fidelity of the optical response obtained, and the entire apparatus as disclosed is conducive to manufacture as a disposable, single-use component which lends itself readily to customary and familiar clinical sterilization techniques, and is also adapted for rapid connection and disconnection to the spectrophotometric control and processing unit.
The foregoing major objectives, advantages and consid¬ erations of the invention, together with and including others, will become more apparent following consideration of the ensuing specification, particularly taken in conjunction with the appended drawings, briefly described hereinafter. Once again it is pointed out that the apparatus and method¬ ology principally described hereinafter constitutes merely a preferred embodiment of the underlying invention, and does not specifically address other and further aspects thereof which will or may become further appreciated by those skilled in the art after consideration of the overall disclosure herein.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a schematic pictorial representation showing a typical operative environment for the apparatus in accordance with the invention, including representative elements thereof;
Fig. 2 is a side elevation of a preferred embodiment of the invention;
Fig. 3 is an enlarged cross-sectional end elevation taken along the plane III-III of Fig. 2;
Fig. 4 is an enlarged cross-sectional end elevation taken along the plane IV-IV of Fig. 2;
Fig. 5 is an enlarged side elevational view of a preferred form of shielding element for use in the apparatus;
Fig. 6 is an enlarged side elevational view of the circuit board which carries the electro-optical components;
Fig. 7 is a fragmentary further enlarged view showing portions of the apparatus shown in Fig. 6;
Fig. 8 is a fragmentary side elevational view showing a portion of the structure of Fig. 6 with certain of the shielding members in place and others partially removed; and
Fig. 9 is a cross-sectional end elevation taken along the plane IX-IX of Fig. 8;
DESCRIPTION OF PREFERRED EMBODIMENTS
Fig. 1 comprises a representative and pictorial showing of a typical clinical setting in which optical spectrophotometric apparatus in accordance with the inven¬ tion is to be used, as part of an operative system for monitoring or examining patients. In fact, Fig. 1 is taken directly from the aforementioned copending application which describes the overall cerebral oximeter system in consider¬ able detail. For purposes of the present disclosure, it need only be said that Fig. 1 shows a human patient 10 who is being monitored by an infrared spectroscopy unit 18 via a sensor unit 12 in accordance with the present invention, which is applied to the forehead of the patient 10 to optically access an internal tissue volume or regional field 14 within the cerebrum, directly adjacent the point where sensor 12 is located, but inside of the scalp, skull, and adjacent dura, i.e., within the brain tissue itself. The sensor unit 12 is coupled to the spectroscopy unit 18 through a conductor bundle 16 described more particularly hereinafter (shown in a bifurcated, divided form for purposes of illustration, although not actually implemented in this particular physical form in the preferred embodiment) . As generally illustrated, the spectroscopy unit 18 includes a digital computer 20 having a monitor 22 on which visual displays may be perceived. It will be noted that the receiver (detector) conductor bundle portion 16a includes an amplification unit 24 disposed a short distance away from the patient 10, as described in more detail hereinafter.
The preferred embodiment of sensor 12 as described herein preferably comprises an elongated, somewhat rectangu¬ lar member (Fig. 2) with rounded corners, from which the conductor bundle 16 extends outwardly. More particularly, sensor assembly 12 preferably comprises a laminar "sandwich" which includes an outer layer (i.e., a cover) having a softly resilient sheet of foam material 26 on the side facing the patient, and an outer backing layer 28 which may be of thinner material which is flexible but not necessarily resilient in character. The two layers 26, 28 are secured together adhesively, and between them is disposed an electrical component board 30 described in more detail hereinafter but adhesively secured in place as a unit so that electro-optical components carried thereon such as photodetectors 32, 34 and a light source 36 are disposed in registration with appropriate apertures 132, 134 and 136 formed in the foam layer 26 (Figs. 3 and 4) , through which such optical components may access the patient 10 (by emitting light which transmisses through the scalp, skull and brain tissue of region 14, and then detecting resultant light after it leaves such region and passes back out of the patient through the skull and scalp, etc.).
The electrical component board 30 is preferably much smaller in overall size than the outer dimensions of the foam layer and backing layer 26, 28 which provide the outwardly visible shape of sensor assembly 12 (as shown in Fig. 2) , and preferably comprises a printed circuit board such as that illustrated in Fig. 6; more particularly, such "printed circuit" board 30 preferably comprises a flex circuit 40, having printed conductive strips 38 secured to one side of a stiffly flexible support strata 40' (Fig. 6). Support strata 40' integrally mounts the aforementioned photodetectors 32 and 34, as well as the light source 36, which are adhesively secured to the support strata and electrically connected to the respective strips 38 by a small wire-like conductor 39. In accordance with the preferred embodiment described herein, source 36 comprises a closely-grouped series of light-emitting diodes (L.E.D. 's)
which are individually excited through particular ones of the strips 38, i.e., strips 38a, 38b and 38c (Fig. 7), in conjunction with a common ground conductor 38d. The conductive strips of flex circuit 40 are electrically connected to the adjacent portion 16a of conductor bundle 16 by soldering the end extremities of the electrical conductors (i.e. wires) 216 inside the conductor bundle 16a to the row of contacts 44 forming the end extremities of conductive strips 38, near one end of the board 30 (Figs. 6 and 8) .
As specifically shown in Fig. 7, there may be several different individual such L.E.D. 's, designated 36a, 36b, 36c, each for producing a specifically selected different light wavelength (as referred to in more detail in the above-identified copending application . It is to be noted, in this connection, that it is also possible to implement the invention in other configurations, e.g., with remotely located light-producing elements and fiberoptic conductors and emitters; however, the preferred configuration illus¬ trated provides certain advantages, particularly in conjunction with present-day L.E.D.s, which can provide surprising amounts of light intensity from a very small component with relatively low excitation. In one specific form presently contemplated as a best mode, the L.E.D.s 36 produce output intensities of about three milliwatts at ninety degree solid angle and require only about five volts d.c. excitation. The photodetectors 32, 34 preferably have sensitivities of about 500 milliamps/watt with peak spectral response at about 900-1000 nm, and are of the low noise type.
As explained at some length in the above-noted copending application, the relative separation of (distance between) the light source 36 and the location of the detec¬ tors 32, 34 is of considerable importance to the particular purpose, function and application of the optical spectrophotometric device with which the sensor assembly 12 is to be used, since these distances effectively determine the location and size of the particular internal region 14
which is to be selectably examined by the interrogating light wavelengths. For the cerebral oximeter which is the subject of the above-mentioned copending application, effective such distances are in the range of approximately 0.3 inches and 1.0 inches, respectively, and these distances thus constitute one particular selectively-determined preferred embodiment and best mode of the present invention; however, in the broader aspects of the underlying invention other and different such distances may be determined and specified without otherwise changing the overall nature of the apparatus and methodology (with the possible exception of specific component choices, since longer such distances may require other and different light intensities, etc. and other applications may require different interrogating wavelengths, etc.) .
In the preferred configuration referred to above and described herein, the electrical component board 30 is preferably covered on both major sides with a thin, stiffly flexible conductive metal layer such as that shown at 42 in Fig. 5, which adds a degree of structural support (i.e., strengthening of the flex circuit) but more importantly provides shielding against otherwise-disruptive or distorting influences such as electromagnetic or electro¬ static fields as well as anomalous ambient light, etc. More particularly, layer 42 shown in Fig. 5 preferably comprises a thin sheet of copper which is of essentially the same outer dimensions as the flex circuit comprising board 30 in the preferred embodiment, and formed with apertures 232, 234 and 236 of a size and shape closely complementary to the outer periphery of the sensors 32 and 34, and the light source 36, i.e., the space immediately surrounding the L.E.D.s 36a, 36b, etc. Thus, layer 42 comprises in effect a mask which fits over the component side of board 30, and is preferably adhesively secured thereto (being electrically insulated from the conductors 38, etc. by the laminate structure of the flex circuit forming board 30, which includes a thin electrically insulating overlay) . As already indicated, the opposite side of the flex circuit is
also preferably covered by a shield layer 42' essentially similar to layer 42, although of course without the apertures since there are no electro-optical components on the reverse side of board 30. That is, the shielding and supportive layer 42' on the non-component side of flex circuit 40 is simply an imperforate sheet of the same conductive material as layer 42, adhesively secured in place.
The laminar "sandwich" described above which forms electrical component board 30 (including the flex circuit 40 together with its components and oppositely-disposed shielding layers 42, 42') is preferably additionally shielded by use of an overlay of conductive sheet material such as a foil-like metal, e.g., copper tape, as designated by the numeral 46 (Fig. 8) , which is wrapped completely around the laminated "sandwich" on all sides except for closely-fitting apertures disposed in registration with apertures 232, 234 and 236 of mask layer 42 (Fig. 5) . In addition, each of the electro-optical components (i.e., source 36 and detectors 32,34) preferably have a shield element 48 (Figs. 8 and 9) in the form of conductive metal mesh or screen which is disposed directly over each of these elements (as a small patch) and which extends over the entire aperture 232, 234 and 236 of shield layer 42 (atop the aforementioned deposit of optically clear epoxy covering each electro-optical component) , as well as under the adjacent edges of the registering apertures formed in the metal tape 46, to lie in electrical contact therewith. The foil-like (tape) shielding layer 46 is preferably secured in place by an electrically-conductive adhesive carried on one side, which integrates the tape into the composite shielding provided. To complete such shielding, conductor bundle 16a is preferably in the form of shielded "co-ax" cable, i.e., having a metallic mesh sleeve 16b (Fig. 2) which peri¬ pherally surrounds the electrical conductors 216 (which are mutually insulated from one another) , and the sheath 16b (or an integral portion thereof) is extended toward and into contact with the outer shielding layer 42 (Fig. 8) of
electrical component board 30, where it is soldered or otherwise secured in place. Sheath 16b is preferably disposed inside a generally tubular, rubber-like outer sleeve 116, which is preferably of an electrically insulating material and also serves esthetic purposes.
Accordingly, it will be appreciated that the electro-optical components, in particular detectors 32 and 34, are extensively shielded by the aforementioned layers 42, 42', 46, mesh patches 48, sheath 16b, etc., since the outer shielding tape layer 46 is also in electrical contact with sheath portion 16b, (through layer 42) and the sheath 16b extends outwardly to the amplifier unit 24, and into contact with a further ground conductor (not specifically shown) contained within conductor bundle 16c, that extends into the spectroscopy unit 18, and is connected to the system ground therewithin. This provides substantial protection against distortion for the comparatively low-level electrical signals produced by detectors 32 and 34 in response to receipt of the selected wavelengths of light from source 36 which have transmissed the region 14 being interrogated. This is an important aspect of the invention, since elimination of distortion, and thus enhanced signal-to-noise ratios, contribute significantly to the overall accuracy and success of the associated spectrophotometric apparatus and procedures. In this regard, the provision of the amplifier unit 24 at a selected distance away from the sensor 12 (e.g., at least about three feet, and preferably about five to six feet) is also a desirable aspect, since this helps to eliminate the presence of higher voltage or current levels at the sensor itself, close to the patient, while at the same time providing for minimal losses of signal between the patient and the spectroscopy unit 18. Of course, the particular attributes of the amplifier 24 should be selectively chosen to complement the electro-optical components as well as to provide the desired input levels for the spectroscopy unit. In addition, the amplifier 24 should be a low-noise device with high input impedance, such as the commercial amplifier
unit known as the AD515 (Analog Devices) . As will be appreciated by those skilled in art, the photodetectors 32, 34 are current-output devices, and as a result the resistivity of the conductors in cable portion 16a is of less significance. The output of amplifier 24, coupled to the spectroscopy unit 18, will be voltage-variant, however.
Further aspects of the preferred form of sensor assembly 12 in accordance with the invention include the following. It is important that the foam layer 26 be of black, light-absorbing material, in order to more effectively isolate ambient light from the electro-optical components 30, 32, 34, as well as to help prevent any possibility of surface leakage between source 36 and detectors 32, 34. This helps ensure that photons received by the detectors have actually transmissed the tissue of the patient, and thus carry desired information. In this connection, the surrounding apertures 132, 134 and 136 for the associated electro-optical components are preferably very closely-fitting (i.e., complementary) to the compo¬ nents, to further enhance such shielding effects. The rear layer 28, of the sensor assembly is preferably opaque to ambient light, i.e., is of dense and highly-reflective material (preferably being white in color) such as an imperforate sheet of polymeric material. In addition, the foam layer 26 is preferably of sufficiently open-celled character as to transmit water vapor from the patient, to prevent moisture build up between the outer face of foam layer 26 and the patient. One acceptable type of such material is polyurethane foam. As noted above, it is quite desirable to provide a small amount of an optically clear material such as epoxy over the light source 36, i.e., the grouped array of L.E.D.s 36a, 36b, etc. as well as over the photodetectors 32, 34, thereby further augmenting the retention of these elements in place atop the flex circuit 40 and, further, effectively filling the air gap which would otherwise exist between the outermost (top) surface of these components and the outer surface of the foam layer 26, where contact is made with the patient. Thus, the optically clear
deposits 50 in effect provide low-loss light guides which actually make contact with the patient (particularly in view of the compressibility of the foam layer 26) to enhance the coupling of light into and out of the patient's tissue. In addition, the deposit over the source 36 somewhat modifies the resulting form of light emission from the L.E.D.s so that they less resemble a point source than would otherwise be true. That is, the desired form of light from source 36 is diffuse in nature, and of course is further diffused by the highly scattering effect of the brain or other tissue to be transmissed.
It is to be pointed out once again that while the foregoing disclosure addresses a particular preferred embodiment, and best mode, the apparatus in accordance with the invention, and that the various recited detailed aspects thereof are regarded as being important to the most pre¬ ferred version of the particular sensor described herein to illustrate the principles and concepts involved in the invention, other embodiments and versions of the invention may well be appropriate in other circumstances. It is therefore to be understood that the foregoing description of a particular preferred embodiment is provided for purposes of description and illustration, and not as a measure of the invention, whose scope is to be defined solely by reference to the ensuing claims. Embodiments of the invention differing from those set forth above which nonetheless utilize the underlying concepts of the invention and incorporate its spirit should therefore be considered as within the scope of the claims appended below, unless such claims by their language specifically state otherwise.
Claims
CLAIMS The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
-1- An optical sender-receiver unit for use as a patient interface device in conducting in vivo spectrophotometric examination procedures, comprising in combination: a main support member of generally thin planar configuration having at least limited longitudinal flexibility; a light source carried by said support member and disposed to emit light of at least two selected wavelengths outwardly thereof and to introduce such light into said patient through a selected surface area; a plurality of electro-optical light detectors carried by said support member at particular spacings from one another and from said light source, said detectors being exposed to receive light from said patient resulting from said introduced light from said source; electrical conduc¬ tors carried at least in part upon said support and coupled to said light detectors to convey output signals therefrom representative of the resultant light received thereby from said patent, said conductors extending outwardly from said support member to a remotely located signal-processing device; and means for shielding said light detectors and at least portions of their said electrical conductors from ambient sources of electrical noise and/or distortion, to help maintain the fidelity of such signals to the detected representative light.
-2- The optical sender-receiver unit as recited in claim 1, wherein said means for shielding includes a thin sheet-like member disposed generally alongside at least portions of said detectors.
-3- The optical sender-receiver unit as recited in claim 2, wherein said means for shielding further includes a sheath surrounding at least portions of said conductors.
-4- The optical sender-receiver unit as recited in claim 3 ,
wherein said thin sheet-like member is electrically coupled to said sheath.
-5- The optical sender-receiver unit as recited in claim 1, and further comprising a circuit board means underlying and supporting said detectors, said circuit board carrying electrically-conductive strips comprising at least in part said conductors coupled to said detectors.
-6- The optical sender-receiver unit as recited in claim 5, wherein said means for shielding includes a thin sheet-like member disposed generally alongside at least portions of said detectors.
-7- The optical sender-receiver unit as recited in claim 6, wherein said thin sheet-like shielding member overlies at least portions of said conductive strips.
-8- The optical sender-receiver unit as recited in claim 7, wherein said thin sheet-like member substantially covers at least portions of said circuit board carrying said conductive strips.
-9- The optical sender-receiver unit as recited in claim 8, wherein said means for shielding further includes a sheath surrounding at least portions of said conductors extending outwardly from said cover, and wherein said thin sheet-like member is electrically coupled to said sheath.
-10- The optical sender-receiver unit as recited in claim 2, wherein said means for shielding includes a thin perforate member overlying said detectors.
-11- The optical sender-receiver unit as recited in claim 10, wherein said perforate member is disposed in contact with said thin sheet-like member.
-12- The optical sender-receiver unit as recited in claim
11, wherein said means for shielding further includes a sheath surrounding at least portions of said conductors.
-13-
The optical sender-receiver unit as recited in claim 11, and further comprising a circuit board means underlying and supporting said detectors, said circuit board carrying electrically-conductive strips comprising at least in part said conductors coupled to said detectors.
-14-
The optical sender-receiver unit as recited in claim
13, wherein said thin sheet-like member comprises at least in part a sheet of conductive foil wrapped about portions of said circuit board means.
-15- The optical sender-receiver unit as recited in claim
14, wherein said perforate member comprises electrically conductive screen-like mesh material.
-16- The optical sender-receiver unit as recited in claim
15, wherein said means for shielding further includes a sheath surrounding at least portions of said conductors, and wherein said foil, said mesh material and said sheath are all electrically interconnected.
-17- An optical sender-receiver unit for use as a patient interface device in conducting in vivo spectrophotometric examination procedures, comprising in combination: an outer cover member having at least limited longitudinal flexibility and a softly resilient material on at least one side, for comfortably contacting a selected surface area on the patient; an electro-optical light source carried with said cover member and exposed through said resilient material, for emitting light of at least two selected wavelengths and introducing such light into said patient at said surface area; a plurality of electro-optical light detectors carried with said cover member at particular spacings from one another and from said light source, said detectors being exposed through said resilient material to
receive light from said patient resulting from said introduced light from said source; electrical conductors coupled to said light source and light detectors to energize said source and to convey output signals from said detectors representative of the resultant light received thereby from said patient, said conductors extending outwardly from said cover member to a remotely located signal-processing device; said source and said detectors comprising low-power compo¬ nents requiring only low levels of current and voltage essentially negligible to human comfort and safety; and electric signal amplification means coupled to receive said output signals from said light detectors via their said electrical conductors for amplification of said signals prior to processing thereof, said amplification means comprising an amplifier unit which is physically located between said patient and said signal-processing device, to protect said patient from higher power levels.
-18- The optical sender-receiver unit as recited in claim 17, wherein said light detectors comprise photodiodes having a sensitivity on the order of about 500 illiamps per watt, and are of a low-noise type.
-19- The optical sender-receiver unit as recited in claim 17, wherein said light source comprises at least one L.E.D. having an output on the order of about three milliwatts and an output light solid angle of about ninety degrees.
-20- The optical sender-receiver unit as recited in claim 17, wherein said amplifier unit is located at least three feet away from said electro-optical light source and detectors.
-21- The optical sender-receiver unit as recited in claim 20, wherein said amplifier unit is located approximately five to six feet away from source and detectors.
-22- The optical sender-receiver unit as recited in claim
18, wherein said light source comprises at least one L.E.D. having an output on the order of about three milliwatts and an output light solid angle of about ninety degrees and, wherein said amplifier unit is located at least three feet away from said electro-optical light source and detectors.
-23-
An optical sender-receiver unit for use as a patient interface device in conducting in vivo spectrophotometric examination procedures, comprising in combination: an outer cover member having at least limited longitudinal flexibility and a softly resilient material on at least one side, for comfortably contacting a selected surface area on the patient; an electro-optical light source carried with said cover member and exposed through said resilient material, for emitting light of at least two selected wavelengths and introducing such light into said patient at said surface area; a plurality of electro-optical light detectors carried with said cover member at particular spacings from one another and from said light source, said detectors being exposed through said resilient material to receive light from said patient resulting from said introduced light from said source; electrical conductors coupled to said light source and light detectors to energize said source and to convey output signals from said detectors representative of the resultant light received thereby from said patent, said conductors extending outwardly from said cover member to a remotely located signal-processing device; said resilient material comprising a sheet-like member of elastomeric foam material which is black in color and therefore highly light-absorbing to thereby help isolate said source from said detectors with respect to light traveling directly therebetween along the surface of the said material as well as helping to isolate said detectors from ambient light.
-24-
The optical sender-receiver unit as recited in claim 23, wherein said cover further includes a flexible sheet disposed on the rearward side of said resilient material
opposite the side contacting said patient to sandwich at least portions of said electo-optical source and detectors therebetween, said cover being of light-reflective material and generally opaque in nature to further isolate said source and detectors from ambient light.
-25- The optical sender-receiver unit as recited in claim 23, wherein said foam is of vapor-transmissive material.
-26- An optical sender-receiver unit for use as a patient interface device in conducting in vivo spectrophotometric examination procedures, comprising in combination: an outer cover member having at least limited longitudinal flexibility and a softly resilient material on at least one side, for comfortably contacting a selected surface area on the patient; an electro-optical light source carried with said cover member and exposed through said resilient material, for emitting light of at least two selected wavelengths and introducing such light into said patient at said surface area; a plurality of electro-optical light detectors carried with said cover member at particular spacings from one another and from said light source, said detectors being exposed through said resilient material to receive light from said patient resulting from said introduced light from said source; electrical conductors coupled to said light source and light detectors to energize said source and to convey output signals from said detectors representative of the resultant light received thereby from said patent, said conductors extending outwardly from said cover member to a remotely located signal-processing device; a support for mounting and positioning said light source and light detectors, said support being disposed adjacent to said resilient material and secured to and carried with such material; and a deposit of optically clear adhesive material disposed over at least one of said light source and light detectors and helping to secure same to said support; said adhesive material forming a light-conductive optical projection which extends toward the patient through at least
portions of said resilient material to contact the skin of the patient and substantially eliminate air gaps between said at least one of said source and detectors and said skin.
-27-
The optical sender-receiver unit as recited in claim 26, wherein said deposit material is electrically insulative in nature to provide additional isolation of the patient from electrical energy present at said unit.
-28-
The optical sender-receiver unit as recited in claim 26, wherein said support comprises a circuit board which carries electrical conductors connected to said source and detectors to provide inputs and/or outputs therefor, said adhesive deposits helping to secure said source, detectors and conductors to said board.
-29-
The optical sender-receiver unit as recited in claim 28, wherein said circuit board comprises a flexible member.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/711,452 US5217013A (en) | 1983-10-14 | 1991-06-06 | Patient sensor for optical cerebral oximeter and the like |
US711,452 | 1991-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992021280A1 true WO1992021280A1 (en) | 1992-12-10 |
Family
ID=24858147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/004743 WO1992021280A1 (en) | 1991-06-06 | 1992-06-04 | Patient headpiece for optical cerebral oximeter |
Country Status (2)
Country | Link |
---|---|
US (1) | US5217013A (en) |
WO (1) | WO1992021280A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0631756A1 (en) * | 1993-06-28 | 1995-01-04 | Hamamatsu Photonics K.K. | Monitoring apparatus |
EP0756847A1 (en) * | 1995-07-31 | 1997-02-05 | JOHNSON & JOHNSON MEDICAL, INC. | Securement system |
WO1997040740A1 (en) * | 1996-04-26 | 1997-11-06 | Ohmeda Inc. | Conformal wrap for pulse oximeter sensor |
US5913819A (en) * | 1996-04-26 | 1999-06-22 | Datex-Ohmeda, Inc. | Injection molded, heat-sealed housing and half-etched lead frame for oximeter sensor |
WO2002089664A2 (en) * | 2001-05-03 | 2002-11-14 | Masimo Corporation | Flex circuit shielded optical sensor and method of fabricating the same |
WO2004069047A1 (en) * | 2003-02-05 | 2004-08-19 | Philips Intellectual Property & Standards Gmbh | Medical sensor |
US9883824B2 (en) | 2012-08-20 | 2018-02-06 | Taiwan Biophotonic Corporation | Detecting device |
US10245508B2 (en) | 2000-11-22 | 2019-04-02 | Intel Corporation | Method and system for providing interactive services over a wireless communications network |
Families Citing this family (149)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541756B2 (en) * | 1991-03-21 | 2003-04-01 | Masimo Corporation | Shielded optical probe having an electrical connector |
US5638818A (en) | 1991-03-21 | 1997-06-17 | Masimo Corporation | Low noise optical probe |
WO1994004073A1 (en) * | 1992-08-25 | 1994-03-03 | Zertl Medical Inc. | Blood flow monitoring system |
JP2547840Y2 (en) * | 1992-09-25 | 1997-09-17 | 日本光電工業株式会社 | Oximeter probe |
DE4304693C2 (en) * | 1993-02-16 | 2002-02-21 | Gerhard Rall | Sensor device for measuring vital parameters of a fetus during childbirth |
JPH09501074A (en) * | 1993-05-20 | 1997-02-04 | ソマネテイツクス コーポレイシヨン | Improved electro-optical sensor for spectrophotometric medical devices |
AU7080594A (en) * | 1993-05-28 | 1994-12-20 | Somanetics Corporation | Method and apparatus for spectrophotometric cerebral oximetry |
US5452717A (en) * | 1993-07-14 | 1995-09-26 | Masimo Corporation | Finger-cot probe |
EP0641543A1 (en) * | 1993-09-07 | 1995-03-08 | Ohmeda Inc. | Heat-sealed neo-natal medical monitoring probe |
US5833622A (en) * | 1994-04-04 | 1998-11-10 | Graphic Controls Corporation | Non-invasive fetal probe having improved mechanical and electrical properties |
US5474065A (en) * | 1994-04-04 | 1995-12-12 | Graphic Controls Corporation | Non-invasive fetal probe |
US5490523A (en) * | 1994-06-29 | 1996-02-13 | Nonin Medical Inc. | Finger clip pulse oximeter |
US5697367A (en) * | 1994-10-14 | 1997-12-16 | Somanetics Corporation | Specially grounded sensor for clinical spectrophotometric procedures |
DE4442855B4 (en) * | 1994-12-01 | 2004-04-01 | Gerhard Dipl.-Ing. Rall | Use of a pulse oximetry sensor device |
US5724967A (en) * | 1995-11-21 | 1998-03-10 | Nellcor Puritan Bennett Incorporated | Noise reduction apparatus for low level analog signals |
US7190984B1 (en) * | 1996-03-05 | 2007-03-13 | Nellcor Puritan Bennett Incorporated | Shunt barrier in pulse oximeter sensor |
US5752914A (en) * | 1996-05-28 | 1998-05-19 | Nellcor Puritan Bennett Incorporated | Continuous mesh EMI shield for pulse oximetry sensor |
US5995857A (en) * | 1996-07-01 | 1999-11-30 | Toomim; I. Hershel | Biofeedback of human central nervous system activity using radiation detection |
US6018673A (en) | 1996-10-10 | 2000-01-25 | Nellcor Puritan Bennett Incorporated | Motion compatible sensor for non-invasive optical blood analysis |
US6002952A (en) | 1997-04-14 | 1999-12-14 | Masimo Corporation | Signal processing apparatus and method |
US6937885B1 (en) | 1997-10-30 | 2005-08-30 | Hypermed, Inc. | Multispectral/hyperspectral medical instrument |
US6199550B1 (en) * | 1998-08-14 | 2001-03-13 | Bioasyst, L.L.C. | Integrated physiologic sensor system |
USRE45616E1 (en) * | 1998-10-13 | 2015-07-21 | Covidien Lp | Multi-channel non-invasive tissue oximeter |
EP1139863B1 (en) * | 1998-12-07 | 2002-09-11 | Lea Medizintechnik GmbH | Detection probe for optical spectroscopy and spectrometry |
US7047054B2 (en) * | 1999-03-12 | 2006-05-16 | Cas Medical Systems, Inc. | Laser diode optical transducer assembly for non-invasive spectrophotometric blood oxygenation monitoring |
US6175751B1 (en) | 1999-03-16 | 2001-01-16 | Allen Maizes | Apparatus and method for sensing oxygen levels in a fetus |
US6675031B1 (en) | 1999-04-14 | 2004-01-06 | Mallinckrodt Inc. | Method and circuit for indicating quality and accuracy of physiological measurements |
TW453862B (en) | 1999-08-30 | 2001-09-11 | Cas Medical Systems Inc | Near infrared spectrophotometric monitoring assembly for non-invasive monitoring of blood oxygenation levels in a subjects's body |
US6577884B1 (en) | 2000-06-19 | 2003-06-10 | The General Hospital Corporation | Detection of stroke events using diffuse optical tomagraphy |
US8224412B2 (en) | 2000-04-17 | 2012-07-17 | Nellcor Puritan Bennett Llc | Pulse oximeter sensor with piece-wise function |
AU2001251654B2 (en) | 2000-04-17 | 2005-03-03 | Nellcor Puritan Bennett Incorporated | Pulse oximeter sensor with piece-wise function |
AU2001259258A1 (en) | 2000-05-02 | 2001-11-12 | Cas Medical Systems, Inc. | Method for non-invasive spectrophotometric blood oxygenation monitoring |
JP2003033328A (en) * | 2001-07-19 | 2003-02-04 | Nippon Seimitsu Sokki Kk | Heart rate monitor and method for measuring heart rate |
US6748254B2 (en) | 2001-10-12 | 2004-06-08 | Nellcor Puritan Bennett Incorporated | Stacked adhesive optical sensor |
EP1545298B1 (en) | 2002-07-26 | 2019-11-27 | Edwards Lifesciences Corporation | Method and apparatus for spectrophotometric blood oxygenation monitoring |
US6850314B2 (en) * | 2002-08-08 | 2005-02-01 | Board Of Reagents University Of Houston | Method for optical sensing |
US7087075B2 (en) * | 2002-09-30 | 2006-08-08 | Medtronic Emergency Response Systems, Inc. | Feedback system for rapid induction of mild hypothermia |
US7179279B2 (en) | 2002-09-30 | 2007-02-20 | Medtronic Physio Control Corp. | Rapid induction of mild hypothermia |
US20040064169A1 (en) * | 2002-09-30 | 2004-04-01 | Briscoe Kathleen E. | User interface for medical device |
US7698909B2 (en) | 2002-10-01 | 2010-04-20 | Nellcor Puritan Bennett Llc | Headband with tension indicator |
EP1549165B8 (en) * | 2002-10-01 | 2010-10-06 | Nellcor Puritan Bennett LLC | Use of a headband to indicate tension and system comprising an oximetry sensor and a headband |
US7190986B1 (en) | 2002-10-18 | 2007-03-13 | Nellcor Puritan Bennett Inc. | Non-adhesive oximeter sensor for sensitive skin |
US7056282B2 (en) * | 2002-12-23 | 2006-06-06 | Medtronic Emergency Response Systems, Inc. | Coolant control for rapid induction of mild hypothermia |
US7047056B2 (en) * | 2003-06-25 | 2006-05-16 | Nellcor Puritan Bennett Incorporated | Hat-based oximeter sensor |
US20050027173A1 (en) * | 2003-07-31 | 2005-02-03 | Briscoe Kathleen E. | Brain injury protocols |
US8412297B2 (en) * | 2003-10-01 | 2013-04-02 | Covidien Lp | Forehead sensor placement |
US7280858B2 (en) * | 2004-01-05 | 2007-10-09 | Masimo Corporation | Pulse oximetry sensor |
US7706853B2 (en) * | 2005-02-10 | 2010-04-27 | Terumo Cardiovascular Systems Corporation | Near infrared spectroscopy device with reusable portion |
US7865223B1 (en) * | 2005-03-14 | 2011-01-04 | Peter Bernreuter | In vivo blood spectrometry |
US8055321B2 (en) | 2005-03-14 | 2011-11-08 | Peter Bernreuter | Tissue oximetry apparatus and method |
US7740588B1 (en) | 2005-06-24 | 2010-06-22 | Michael Sciarra | Wireless respiratory and heart rate monitoring system |
US7590439B2 (en) | 2005-08-08 | 2009-09-15 | Nellcor Puritan Bennett Llc | Bi-stable medical sensor and technique for using the same |
US7657294B2 (en) | 2005-08-08 | 2010-02-02 | Nellcor Puritan Bennett Llc | Compliant diaphragm medical sensor and technique for using the same |
US7657295B2 (en) | 2005-08-08 | 2010-02-02 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US20070060808A1 (en) | 2005-09-12 | 2007-03-15 | Carine Hoarau | Medical sensor for reducing motion artifacts and technique for using the same |
US7869850B2 (en) | 2005-09-29 | 2011-01-11 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
US7904130B2 (en) | 2005-09-29 | 2011-03-08 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US7899510B2 (en) | 2005-09-29 | 2011-03-01 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US8092379B2 (en) | 2005-09-29 | 2012-01-10 | Nellcor Puritan Bennett Llc | Method and system for determining when to reposition a physiological sensor |
US7881762B2 (en) | 2005-09-30 | 2011-02-01 | Nellcor Puritan Bennett Llc | Clip-style medical sensor and technique for using the same |
US8233954B2 (en) | 2005-09-30 | 2012-07-31 | Nellcor Puritan Bennett Llc | Mucosal sensor for the assessment of tissue and blood constituents and technique for using the same |
US8062221B2 (en) | 2005-09-30 | 2011-11-22 | Nellcor Puritan Bennett Llc | Sensor for tissue gas detection and technique for using the same |
US7483731B2 (en) | 2005-09-30 | 2009-01-27 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US7555327B2 (en) | 2005-09-30 | 2009-06-30 | Nellcor Puritan Bennett Llc | Folding medical sensor and technique for using the same |
US7486979B2 (en) | 2005-09-30 | 2009-02-03 | Nellcor Puritan Bennett Llc | Optically aligned pulse oximetry sensor and technique for using the same |
US7729773B2 (en) * | 2005-10-19 | 2010-06-01 | Advanced Neuromodualation Systems, Inc. | Neural stimulation and optical monitoring systems and methods |
US8965472B2 (en) * | 2005-10-21 | 2015-02-24 | Cas Medical Systems, Inc. | Method and apparatus for spectrophotometric based oximetry |
US8073518B2 (en) | 2006-05-02 | 2011-12-06 | Nellcor Puritan Bennett Llc | Clip-style medical sensor and technique for using the same |
US10188348B2 (en) | 2006-06-05 | 2019-01-29 | Masimo Corporation | Parameter upgrade system |
US8145288B2 (en) | 2006-08-22 | 2012-03-27 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US8219170B2 (en) | 2006-09-20 | 2012-07-10 | Nellcor Puritan Bennett Llc | System and method for practicing spectrophotometry using light emitting nanostructure devices |
US8396527B2 (en) | 2006-09-22 | 2013-03-12 | Covidien Lp | Medical sensor for reducing signal artifacts and technique for using the same |
US8175671B2 (en) | 2006-09-22 | 2012-05-08 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US8190225B2 (en) | 2006-09-22 | 2012-05-29 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US7869849B2 (en) | 2006-09-26 | 2011-01-11 | Nellcor Puritan Bennett Llc | Opaque, electrically nonconductive region on a medical sensor |
US7574245B2 (en) | 2006-09-27 | 2009-08-11 | Nellcor Puritan Bennett Llc | Flexible medical sensor enclosure |
US7796403B2 (en) | 2006-09-28 | 2010-09-14 | Nellcor Puritan Bennett Llc | Means for mechanical registration and mechanical-electrical coupling of a faraday shield to a photodetector and an electrical circuit |
US7890153B2 (en) | 2006-09-28 | 2011-02-15 | Nellcor Puritan Bennett Llc | System and method for mitigating interference in pulse oximetry |
US8068891B2 (en) | 2006-09-29 | 2011-11-29 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US8175667B2 (en) | 2006-09-29 | 2012-05-08 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US7680522B2 (en) | 2006-09-29 | 2010-03-16 | Nellcor Puritan Bennett Llc | Method and apparatus for detecting misapplied sensors |
US7476131B2 (en) | 2006-09-29 | 2009-01-13 | Nellcor Puritan Bennett Llc | Device for reducing crosstalk |
US7684842B2 (en) | 2006-09-29 | 2010-03-23 | Nellcor Puritan Bennett Llc | System and method for preventing sensor misuse |
US7880626B2 (en) | 2006-10-12 | 2011-02-01 | Masimo Corporation | System and method for monitoring the life of a physiological sensor |
US8428674B2 (en) * | 2006-11-14 | 2013-04-23 | Cas Medical Systems, Inc. | Apparatus for spectrometric based oximetry |
US8100834B2 (en) | 2007-02-27 | 2012-01-24 | J&M Shuler, Inc. | Method and system for monitoring oxygenation levels of a compartment for detecting conditions of a compartment syndrome |
US8639309B2 (en) | 2007-07-31 | 2014-01-28 | J&M Shuler, Inc. | Method and system for monitoring oxygenation levels of compartments and tissue |
US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
US7894869B2 (en) | 2007-03-09 | 2011-02-22 | Nellcor Puritan Bennett Llc | Multiple configuration medical sensor and technique for using the same |
US9622694B2 (en) | 2007-06-20 | 2017-04-18 | Vioptix, Inc. | Measuring cerebral oxygen saturation |
US8929967B2 (en) * | 2007-06-25 | 2015-01-06 | Vioptix, Inc. | Noninvasive sensor housing |
US20090108205A1 (en) * | 2007-10-10 | 2009-04-30 | Cas Medical Systems, Inc. | Nirs sensor mounting apparatus |
US8352004B2 (en) | 2007-12-21 | 2013-01-08 | Covidien Lp | Medical sensor and technique for using the same |
US8346328B2 (en) | 2007-12-21 | 2013-01-01 | Covidien Lp | Medical sensor and technique for using the same |
US8366613B2 (en) | 2007-12-26 | 2013-02-05 | Covidien Lp | LED drive circuit for pulse oximetry and method for using same |
US8577434B2 (en) | 2007-12-27 | 2013-11-05 | Covidien Lp | Coaxial LED light sources |
US20090171176A1 (en) * | 2007-12-28 | 2009-07-02 | Nellcor Puritan Bennett Llc | Snapshot Sensor |
US8452364B2 (en) | 2007-12-28 | 2013-05-28 | Covidien LLP | System and method for attaching a sensor to a patient's skin |
US8442608B2 (en) | 2007-12-28 | 2013-05-14 | Covidien Lp | System and method for estimating physiological parameters by deconvolving artifacts |
US8897850B2 (en) | 2007-12-31 | 2014-11-25 | Covidien Lp | Sensor with integrated living hinge and spring |
US8092993B2 (en) | 2007-12-31 | 2012-01-10 | Nellcor Puritan Bennett Llc | Hydrogel thin film for use as a biosensor |
US8070508B2 (en) | 2007-12-31 | 2011-12-06 | Nellcor Puritan Bennett Llc | Method and apparatus for aligning and securing a cable strain relief |
US8199007B2 (en) | 2007-12-31 | 2012-06-12 | Nellcor Puritan Bennett Llc | Flex circuit snap track for a biometric sensor |
KR101506177B1 (en) * | 2008-01-10 | 2015-03-26 | 삼성전자주식회사 | Sensor for measuring physiological signal and method for manufacturing thereof |
US8437822B2 (en) | 2008-03-28 | 2013-05-07 | Covidien Lp | System and method for estimating blood analyte concentration |
US8112375B2 (en) | 2008-03-31 | 2012-02-07 | Nellcor Puritan Bennett Llc | Wavelength selection and outlier detection in reduced rank linear models |
EP2306892A1 (en) * | 2008-04-15 | 2011-04-13 | Nonin Medical, Inc | Non-invasive optical sensor |
US7887345B2 (en) * | 2008-06-30 | 2011-02-15 | Nellcor Puritan Bennett Llc | Single use connector for pulse oximetry sensors |
US8071935B2 (en) | 2008-06-30 | 2011-12-06 | Nellcor Puritan Bennett Llc | Optical detector with an overmolded faraday shield |
US7880884B2 (en) * | 2008-06-30 | 2011-02-01 | Nellcor Puritan Bennett Llc | System and method for coating and shielding electronic sensor components |
US8257274B2 (en) | 2008-09-25 | 2012-09-04 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US8364220B2 (en) | 2008-09-25 | 2013-01-29 | Covidien Lp | Medical sensor and technique for using the same |
EP2168475B1 (en) * | 2008-09-25 | 2012-03-07 | NeMoDevices AG | Device for diagnosis and/or therapy of physiological characteristics of a selected portion of a body by optical reflectance or optical transmission |
US8914088B2 (en) | 2008-09-30 | 2014-12-16 | Covidien Lp | Medical sensor and technique for using the same |
US8417309B2 (en) | 2008-09-30 | 2013-04-09 | Covidien Lp | Medical sensor |
US20100081904A1 (en) * | 2008-09-30 | 2010-04-01 | Nellcor Puritan Bennett Llc | Device And Method For Securing A Medical Sensor to An Infant's Head |
US8423112B2 (en) * | 2008-09-30 | 2013-04-16 | Covidien Lp | Medical sensor and technique for using the same |
US8725226B2 (en) | 2008-11-14 | 2014-05-13 | Nonin Medical, Inc. | Optical sensor path selection |
US8452358B2 (en) * | 2009-03-02 | 2013-05-28 | Covidien Lp | Optical-based physiological sensor assembly with disposable barrier layer |
US8452366B2 (en) | 2009-03-16 | 2013-05-28 | Covidien Lp | Medical monitoring device with flexible circuitry |
US8221319B2 (en) | 2009-03-25 | 2012-07-17 | Nellcor Puritan Bennett Llc | Medical device for assessing intravascular blood volume and technique for using the same |
US8515515B2 (en) | 2009-03-25 | 2013-08-20 | Covidien Lp | Medical sensor with compressible light barrier and technique for using the same |
US8781548B2 (en) * | 2009-03-31 | 2014-07-15 | Covidien Lp | Medical sensor with flexible components and technique for using the same |
US8509869B2 (en) | 2009-05-15 | 2013-08-13 | Covidien Lp | Method and apparatus for detecting and analyzing variations in a physiologic parameter |
US8571619B2 (en) | 2009-05-20 | 2013-10-29 | Masimo Corporation | Hemoglobin display and patient treatment |
US8634891B2 (en) | 2009-05-20 | 2014-01-21 | Covidien Lp | Method and system for self regulation of sensor component contact pressure |
US20100331640A1 (en) * | 2009-06-26 | 2010-12-30 | Nellcor Puritan Bennett Llc | Use of photodetector array to improve efficiency and accuracy of an optical medical sensor |
US8311601B2 (en) | 2009-06-30 | 2012-11-13 | Nellcor Puritan Bennett Llc | Reflectance and/or transmissive pulse oximeter |
US9010634B2 (en) | 2009-06-30 | 2015-04-21 | Covidien Lp | System and method for linking patient data to a patient and providing sensor quality assurance |
US8505821B2 (en) | 2009-06-30 | 2013-08-13 | Covidien Lp | System and method for providing sensor quality assurance |
US8391941B2 (en) | 2009-07-17 | 2013-03-05 | Covidien Lp | System and method for memory switching for multiple configuration medical sensor |
US8417310B2 (en) | 2009-08-10 | 2013-04-09 | Covidien Lp | Digital switching in multi-site sensor |
US8428675B2 (en) | 2009-08-19 | 2013-04-23 | Covidien Lp | Nanofiber adhesives used in medical devices |
US20110237910A1 (en) * | 2010-03-23 | 2011-09-29 | Cas Medical Systems, Inc. | Stabilized multi-wavelength laser system for non-invasive spectrophotometric monitoring |
ES2821490T3 (en) | 2010-03-30 | 2021-04-26 | The Childrens Res Institute | Human algometry apparatus and method |
US7884933B1 (en) | 2010-05-05 | 2011-02-08 | Revolutionary Business Concepts, Inc. | Apparatus and method for determining analyte concentrations |
KR20140034118A (en) | 2010-11-03 | 2014-03-19 | 유니버시티 오브 워싱톤 스루 이츠 센터 포 커머셜리제이션 | Deternimation of tissue oxygenation in vivo |
US10321862B2 (en) * | 2011-02-13 | 2019-06-18 | Cas Medical Systems, Inc. | NIRS sensor assembly including electrically conductive and optically transparent EMI shielding |
US9049893B2 (en) | 2011-02-25 | 2015-06-09 | Covidien Lp | Device for securing a medical sensor |
US8577440B2 (en) | 2011-03-29 | 2013-11-05 | Covidien Lp | Method and system for positioning a sensor |
US9220436B2 (en) | 2011-09-26 | 2015-12-29 | Covidien Lp | Technique for remanufacturing a BIS sensor |
US9192330B2 (en) | 2012-02-27 | 2015-11-24 | Covidien Lp | System and method for storing and providing patient-related data |
US9693697B2 (en) * | 2012-03-29 | 2017-07-04 | Benny Tal | Hand-held device having health monitoring capabilities |
US10004421B2 (en) * | 2013-09-13 | 2018-06-26 | Altec, Inc. | Disposable protective overlay covering for biomedical sensors |
US10098576B2 (en) | 2014-03-14 | 2018-10-16 | Covidien Lp | Regional saturation shock detection method and system |
USD763939S1 (en) | 2014-04-02 | 2016-08-16 | Cephalogics, LLC | Optical sensor array liner with optical sensor array pad |
USD763938S1 (en) | 2014-04-02 | 2016-08-16 | Cephalogics, LLC | Optical sensor array |
WO2018070035A1 (en) * | 2016-10-14 | 2018-04-19 | 株式会社フジタ医科器械 | Biological information measurement instrument |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321930A (en) * | 1977-06-28 | 1982-03-30 | Duke University, Inc. | Apparatus for monitoring metabolism in body organs |
US4819752A (en) * | 1987-10-02 | 1989-04-11 | Datascope Corp. | Blood constituent measuring device and method |
US4825879A (en) * | 1987-10-08 | 1989-05-02 | Critkon, Inc. | Pulse oximeter sensor |
US4865038A (en) * | 1986-10-09 | 1989-09-12 | Novametrix Medical Systems, Inc. | Sensor appliance for non-invasive monitoring |
WO1989009566A1 (en) * | 1988-04-05 | 1989-10-19 | Datascope Corp. | Radiation sensor for monitoring a body condition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880304A (en) * | 1987-04-01 | 1989-11-14 | Nippon Colin Co., Ltd. | Optical sensor for pulse oximeter |
DE3809084C2 (en) * | 1988-03-18 | 1999-01-28 | Nicolay Gmbh | Sensor for the non-invasive measurement of the pulse frequency and / or the oxygen saturation of the blood and method for its production |
US4964408A (en) * | 1988-04-29 | 1990-10-23 | Thor Technology Corporation | Oximeter sensor assembly with integral cable |
US5111817A (en) * | 1988-12-29 | 1992-05-12 | Medical Physics, Inc. | Noninvasive system and method for enhanced arterial oxygen saturation determination and arterial blood pressure monitoring |
-
1991
- 1991-06-06 US US07/711,452 patent/US5217013A/en not_active Expired - Lifetime
-
1992
- 1992-06-04 WO PCT/US1992/004743 patent/WO1992021280A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321930A (en) * | 1977-06-28 | 1982-03-30 | Duke University, Inc. | Apparatus for monitoring metabolism in body organs |
US4510938A (en) * | 1977-06-28 | 1985-04-16 | Duke University, Inc. | Body-mounted light source-detector apparatus |
US4865038A (en) * | 1986-10-09 | 1989-09-12 | Novametrix Medical Systems, Inc. | Sensor appliance for non-invasive monitoring |
US4819752A (en) * | 1987-10-02 | 1989-04-11 | Datascope Corp. | Blood constituent measuring device and method |
US4825879A (en) * | 1987-10-08 | 1989-05-02 | Critkon, Inc. | Pulse oximeter sensor |
WO1989009566A1 (en) * | 1988-04-05 | 1989-10-19 | Datascope Corp. | Radiation sensor for monitoring a body condition |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0631756A1 (en) * | 1993-06-28 | 1995-01-04 | Hamamatsu Photonics K.K. | Monitoring apparatus |
EP0756847A1 (en) * | 1995-07-31 | 1997-02-05 | JOHNSON & JOHNSON MEDICAL, INC. | Securement system |
WO1997040740A1 (en) * | 1996-04-26 | 1997-11-06 | Ohmeda Inc. | Conformal wrap for pulse oximeter sensor |
US5913819A (en) * | 1996-04-26 | 1999-06-22 | Datex-Ohmeda, Inc. | Injection molded, heat-sealed housing and half-etched lead frame for oximeter sensor |
US5919133A (en) * | 1996-04-26 | 1999-07-06 | Ohmeda Inc. | Conformal wrap for pulse oximeter sensor |
US10245508B2 (en) | 2000-11-22 | 2019-04-02 | Intel Corporation | Method and system for providing interactive services over a wireless communications network |
WO2002089664A2 (en) * | 2001-05-03 | 2002-11-14 | Masimo Corporation | Flex circuit shielded optical sensor and method of fabricating the same |
WO2002089664A3 (en) * | 2001-05-03 | 2003-03-13 | Masimo Corp | Flex circuit shielded optical sensor and method of fabricating the same |
US6985764B2 (en) | 2001-05-03 | 2006-01-10 | Masimo Corporation | Flex circuit shielded optical sensor |
WO2004069047A1 (en) * | 2003-02-05 | 2004-08-19 | Philips Intellectual Property & Standards Gmbh | Medical sensor |
US7379764B2 (en) | 2003-02-05 | 2008-05-27 | Koninklijke Philips Electronics N.V. | Medical sensor |
US9883824B2 (en) | 2012-08-20 | 2018-02-06 | Taiwan Biophotonic Corporation | Detecting device |
Also Published As
Publication number | Publication date |
---|---|
US5217013A (en) | 1993-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5217013A (en) | Patient sensor for optical cerebral oximeter and the like | |
US5584296A (en) | Patient sensor for optical cerebral oximeters and the like | |
CA2724017C (en) | Non-invasive optical sensor | |
US5697367A (en) | Specially grounded sensor for clinical spectrophotometric procedures | |
US8229533B2 (en) | Low-noise optical probes for reducing ambient noise | |
TW453862B (en) | Near infrared spectrophotometric monitoring assembly for non-invasive monitoring of blood oxygenation levels in a subjects's body | |
KR101307212B1 (en) | Biosensor device | |
US9364181B2 (en) | Physiological sensor combination | |
US10321862B2 (en) | NIRS sensor assembly including electrically conductive and optically transparent EMI shielding | |
US20100049018A1 (en) | Apparatus for spectrometric based oximetry | |
EP0104772A2 (en) | Calibrated optical oximeter probe | |
US20050209516A1 (en) | Vital signs probe | |
US20020165440A1 (en) | Flex circuit shielded optical sensor | |
WO2010082748A2 (en) | Form of a sensor module for measuring a photoplethysmogram for removing a motion artifact and method | |
JP2016500290A (en) | Method for determining blood oxygen parameters by spectrophotometry | |
EP0329196B1 (en) | Oximeter for cooperation with an oximeter probe | |
US20230309869A1 (en) | Probe device and spectroscopy system including a structure with a plurality of housings for lighting and detection devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP KR |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |